Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Adaptive Biotechnologies Corporation (ADPT)

48.63   0.59 (1.23%) 09-30 18:12
Open: 47.51 Pre. Close: 48.04
High: 48.76 Low: 47.2
Volume: 685,886 Market Cap: 6,604M
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. The company is headquartered in Seattle, Washington and currently employs 346 full-time employees. The firm is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform generates clinical immunomics data to decode the adaptive immune system. Its products and pipeline includes immunoSEQ, clonoSEQ and cellular therapy. The company offers its immunoSEQ technology as a service and a kit. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). clonoSEQ is its diagnostic test product for the detection and next-generation sequencing (NGS)-based monitoring of minimal residual disease (MRD) in bone marrow samples in patients with myeloma (MM) and acute lymphoblastic leukemia (ALL). clonoSEQ is designed to sequence all rearranged receptor sequences in a tumor in parallel to enable MRD monitoring. The company also focuses on developing immune-mediated therapies in oncology and other disease areas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 48.796 - 49.027 49.027 - 49.244
Low: 46.61 - 46.875 46.875 - 47.124
Close: 48.191 - 48.611 48.611 - 49.006

Technical analysis

as of: 2020-09-30 4:38:18 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 59.21     One year: 69.16
Support: Support1: 40.84    Support2: 34.75
Resistance: Resistance1: 50.70    Resistance2: 59.21
Pivot: 45.83
Moving Average: MA(5): 47.83     MA(20): 43.81
MA(100): 41.84     MA(250): 33.85
MACD: MACD(12,26): 2.11     Signal(9): 1.70
Stochastic oscillator: %K(14,3): 86.93     %D(3): 89.45
RSI: RSI(14): 65.08
52-week: High: 50.70  Low: 15.19  Change(%): 57.3
Average Vol(K): 3-Month: 107469  10-Days: 126543

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ADPT has closed below upper band by 25.8%. Bollinger Bands are 28.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 30 Sep 2020
Adaptive Biotechnologies Corporation (ADPT) market price of $48.04 offers the impression of an exciting value play - The InvestChronicle

Wed, 30 Sep 2020
Adaptive Biotechnologies Corporation (ADPT): What is good about stock? - Marketing Sentinel

Wed, 30 Sep 2020
Is a Correction Looming Ahead for Adaptive Biotechnologies Corporation (ADPT) - The News Heater

Tue, 29 Sep 2020
Strong Buy Adaptive Biotechnologies Corporation [ADPT] Stock Before Shares Hit Major Turbulence - MZP News

Tue, 29 Sep 2020
Adaptive Biotechnologies Corp (ADPT) Stock: Buy, Hold, or Sell? - InvestorsObserver

Mon, 28 Sep 2020
Do Hedge Funds Love Adaptive Biotechnologies Corporation (ADPT)? - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 136
Shares Float (M) 82
% Held by Insiders 5.47
% Held by Institutions 73.44
Shares Short (K) 3,040
Shares Short P. Month (K) 2,210

Stock Financials

EPS -0.790
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.130
Profit Margin -107.96
Operating Margin -123.44
Return on Assets (ttm) -9.8
Return on Equity (ttm) -24.6
Qtrly Rev. Growth -5.2
Gross Profit (p.s.) -0.058
Sales Per Share 0.679
EBITDA (p.s.) -0.778
Qtrly Earnings Growth
Operating Cash Flow (M) -120
Levered Free Cash Flow (M) -51

Stock Valuations

PE Ratio -61.56
PEG Ratio
Price to Book value 11.77
Price to Sales 71.64
Price to Cash Flow -55.21

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.